Paper33536909
Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.
Salehi B and 16 others. Front Pharmacol, 2020. Cited by 191 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Papers, record 33536909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33536909
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References171
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24882415 | Newly synthesized 'hidabeni' chalcone derivatives potently suppress LPS-induced NO production via inhibition of STAT1, but not NF-κB, JNK, and p38, pathways in microglia. | Biol Pharm Bull | 2014 | https://conductscience.org/library/papers/24882415 | PubMed |
| 2 | 8092835 | Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8092835 | PubMed |
| 3 | 30622011 | Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors. | Bioorg Chem | 2019 | https://conductscience.org/library/papers/30622011 | PubMed |
| 4 | 17276410 | Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. | Biochem Pharmacol | 2007 | https://conductscience.org/library/papers/17276410 | PubMed |
| 5 | 12650848 | ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties. | Eur J Pharmacol | 2003 | https://conductscience.org/library/papers/12650848 | PubMed |
| 6 | 22020493 | Antifungal activity of phenolic-rich Lavandula multifida L. essential oil. | Eur J Clin Microbiol Infect Dis | 2012 | https://conductscience.org/library/papers/22020493 | PubMed |
| 7 | 12161067 | Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase. | Eur J Med Chem | 2002 | https://conductscience.org/library/papers/12161067 | PubMed |
| 8 | 24262065 | In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin. | Phytomedicine | 2014 | https://conductscience.org/library/papers/24262065 | PubMed |
| 9 | 14612852 | Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. | Int Angiol | 2003 | https://conductscience.org/library/papers/14612852 | PubMed |
| 10 | 26293170 | A double-blinded, randomized, vehicle-controlled study to access skin tolerability and efficacy of an anti-inflammatory moisturizer in treatment of acne with 0.1% adapalene gel. | J Dermatolog Treat | 2016 | https://conductscience.org/library/papers/26293170 | PubMed |
| 11 | 7575989 | Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships. | Anticancer Drug Des | 1995 | https://conductscience.org/library/papers/7575989 | PubMed |
| 12 | 28971779 | New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. | Anticancer Agents Med Chem | 2018 | https://conductscience.org/library/papers/28971779 | PubMed |
| 13 | 32714204 | Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. | Front Physiol | 2020 | https://conductscience.org/library/papers/32714204 | PubMed |
| 14 | 19747522 | Nitrochalcones: potential in vivo insulin secretagogues. | Biochimie | 2009 | https://conductscience.org/library/papers/19747522 | PubMed |
| 15 | 20005707 | Synthesis and biological evaluation of nitrogen-containing chalcones as possible anti-inflammatory and antioxidant agents. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20005707 | PubMed |
| 16 | 16462036 | Glycosidase inhibitory flavonoids from Sophora flavescens. | Biol Pharm Bull | 2006 | https://conductscience.org/library/papers/16462036 | PubMed |
| 17 | 15184014 | Geranyl chalcone derivatives with antifungal and radical scavenging properties from the leaves of Artocarpus nobilis. | Phytochemistry | 2004 | https://conductscience.org/library/papers/15184014 | PubMed |
| 18 | 11504637 | In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. | Bioorg Med Chem | 2001 | https://conductscience.org/library/papers/11504637 | PubMed |
| 19 | 17095211 | Chalcone based aryloxypropanolamines as potential antihyperglycemic agents. | Bioorg Med Chem Lett | 2007 | https://conductscience.org/library/papers/17095211 | PubMed |
| 20 | 28300756 | Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28300756 | PubMed |
Cited by126
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 191 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42898690 | Paraptosis, a new type of cell death that can be applied to cancer treatment. | Front Oncol | 2026 | https://conductscience.org/library/papers/42898690 | PubMed |
| 42552245 | Bioactive Natural and Synthetic Chalcones: Brazil as a Research Powerhouse in Discovery and Innovation. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42552245 | PubMed |
| 42515657 | Chalcones as a Versatile Antiviral Scaffold: Molecular Targets, ADMET Profiles, and Translational Challenges. | Viruses | 2026 | https://conductscience.org/library/papers/42515657 | PubMed |
| 42357354 | Flavonoids as Modulators of the p53-Bcl-2 Axis in Cancer: Molecular Mechanisms and Therapeutic Implications. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357354 | PubMed |
| 42324341 | Phenothiazine dye-loaded chitosan cryogels as multifunctional antibacterial wound dressings. | Sci Rep | 2026 | https://conductscience.org/library/papers/42324341 | PubMed |
| 42218186 | Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways. | Sci Rep | 2026 | https://conductscience.org/library/papers/42218186 | PubMed |
| 42198655 | Discovery of Synthetic Imine-Chalcones Targeting Mayaro Virus Replication. | Pathogens | 2026 | https://conductscience.org/library/papers/42198655 | PubMed |
| 42188295 | Schoenoplectus californicus (C.A. Mey.) Soják: Chemical Profile, Antioxidant Capacity, Psychopharmacological Exploration and Analgesic Activity. | Mar Drugs | 2026 | https://conductscience.org/library/papers/42188295 | PubMed |
| 42101574 | In Vitro Evaluation of Novel Synthetic Benzimidazolium-Chalcone Hybrids: Antioxidant and Regenerative Effects in Diabetic Wound Healing. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42101574 | PubMed |
| 42078935 | Developmental and angiogenic safety profiles of novel pyridine-based chalcone. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42078935 | PubMed |
| 42035226 | Design, Synthesis, and Evaluation of New Polyhydroxylated Bis-Chalcones as Potential COX-2 Selective Inhibitors. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42035226 | PubMed |
| 41993994 | Structure-property relationships in chalcones with extended π-conjugation: ICT perturbation and red fluorescence. | Mater Adv | 2026 | https://conductscience.org/library/papers/41993994 | PubMed |
| 41898570 | Nitrochalcones: Pharmacological Activities and Therapeutic Potential. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898570 | PubMed |
| 41742613 | Chalcones as Multi-target Ligands for Alzheimer's Disease: A Review of Synthetic Strategies and Therapeutic Promise. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41742613 | PubMed |
| 41739383 | Medicinal chemistry perspective of chalcone derivatives as anticancer agents: synthetic strategy, biological activity, and structure-activity relationship. | Mol Divers | 2026 | https://conductscience.org/library/papers/41739383 | PubMed |
| 41726615 | Activity-Selectivity of Flavonoid Derivatives in Endometriotic Cells. | ACS Omega | 2026 | https://conductscience.org/library/papers/41726615 | PubMed |
| 41596305 | Biological Roles of Melanin and Natural Product-Derived Approaches for Its Modulation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596305 | PubMed |
| 41590617 | Bioactive Ingredient Profiling of Dendrobium officinale: Plant-Part-Specific Distribution of Key Metabolites and Their Multi-Disease Therapeutic Potential. | Metabolites | 2025 | https://conductscience.org/library/papers/41590617 | PubMed |
| 41375124 | Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors. | Molecules | 2025 | https://conductscience.org/library/papers/41375124 | PubMed |
| 41340711 | Relaxation Dynamics in Dihydroxychalcones: Insights from Ultrafast Spectroscopy and Quantum Computations. | ACS Phys Chem Au | 2025 | https://conductscience.org/library/papers/41340711 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33536909
GET https://conductscience.org/api/papers/v1/33536909/references?page=2